[Event Report] The Second Meeting of Working Group 5 on Vaccine Research and Development, “The Next Actions to Ensure the Development and Implementation of Immunization and Vaccine Policies” (January 17, 2022)
date : 1/28/2022
Tags: Vaccinations
On January 17, 2022, Health and Global Policy Institute (HGPI) held the second meeting of Working Group 5 on vaccine research and development for “Next Actions for the Development and Implementation of Immunization and Vaccination Policies.”
This meeting was the second working group meeting on the R&D and production pipeline and, based on points raised at the previous meeting, examined the next steps needed to reinforce the vaccine R&D and production pipeline in the future. A multi-stakeholder group of experts in the field deepened discussions on the pharmaceutical regulation system for vaccines and the ability of the vaccine R&D and production systems, which are undergoing rapid investigation during the ongoing Coronavirus Disease 2019 (COVID-19) pandemic, to provide leadership and coordination.
To prevent the potential spread of COVID-19, this meeting was held online using a remote conferencing system.
■2021 Advisory Board Working Group 5 (Titles omitted; in alphabetical order by last name)
Members:
Ken J. Ishii (Professor, Division of Vaccine Science, Institute of Medical Science, The University of Tokyo/ Director, International Vaccine Design Center, Institute of Medical Science)
Masayuki Imagawa (Chief Executive, Japan Vaccine Industry Association/ Vice President & Head, Japan Vaccine Business Unit, Takeda Pharmaceutical Co., Ltd.)
Hiroshi Kasanuki (Specially Appointed Professor, Waseda University/ Advisor, Institute for Medical Regulatory Science, Waseda University)
Kengo Sonoda (General Manager, Development Department, R&D Division, KM Biologics Co., Ltd.)
Hideki Hasegawa (Director, Center for Influenza and Respiratory Virus Research, National Institute of Infectious Diseases)
Yoshiharu Matsuura (Director, Center for Infectious Disease Education and Research (CiDER))
Shinji Matsumoto (Chair, Vaccines Working Team, EFPIA Japan)
Isao Miyairi (Professor, Faculty of Pediatrics, Hamamatsu University School of Medicine)
Yoshiaki Yamagishi (Associate Professor, Medical Center of Translational Research, Department of Medical Innovation, Osaka University)
Observer:
Yasuhiro Araki (Director, Office of Vaccine and Blood Products, Pharmaceuticals and Medical Devices Agency)
MC/Moderator
Takahiro Sakauchi (Associate, Health and Global Policy Institute)
Event Overview
Joji Sugawara (Manager, Health and Global Policy Institute)
■Related contents held as part of the project
– November 4, 2021 The First Meeting of Working Group 5 on Vaccine Research and Development, “Next Actions for the Development and Implementation of Immunization and Vaccination Policies”
日本語
Top Research & Recommendations Posts
- [Announcement] HGPI Joins Alliance for Transformative Action on Climate and Health (April 22, 2024)
- [Announcement] A Significant Step Towards the Building a Green Healthcare System: Support for the Formal Expression of Interest by the Japanese Government Delegation to the ATACH at the Executive Board Meeting of the WHO (February 16, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Event Report] Planetary Health Expert Meeting Aiming for Sustainable Healthcare: Learning from the Impact of Environmental Pollution and Medical Waste During the Pandemic (February 16, 2024)
- [Publication Report] Developing and Expanding Cardiovascular Disease Control Plans in Each Prefecture – Challenges and Good Examples for Cardiovascular Disease Control (September 7, 2023)
- [Public Comment Submission] Opinions Regarding the Proposed “National Action Plan on Antimicrobial Resistance 2023-2027 (Draft)” (March 16, 2023)
- [Report and Recommendations] Discussion Points in Healthcare DX Project Expert Panel Meeting (April 2, 2024)
Featured Posts
-
2024-04-22
[Registration Open] (Hybrid Format) Intractable Disease Day Symposium: Future Measures for Intractable Diseases from the Perspectives of Patients and Citizens (May, 23 2024)
-
2024-04-23
[Registration Open] (Webinar) The 125th HGPI Seminar: Progress and Prospects for Domestic Measures on Health Problems Caused by Alcohol (May 24 , 2024)
-
2024-04-30
[Event Report] Non-partisan Diet Member Briefing – 30-minute Health Policy Update: “Community Development for Senior Health: From Establishing Evidence to Social Implementation” (April 23, 2024)
-
2024-05-02
[Event Report] The 123rd HGPI Seminar – The Current Situation and Future Prospects for Epilepsy in Japan and Around the World (March 6, 2024)
-
2024-05-09
[Registration Open] The Health Policy Academy the 13th Session